WARRENDALE, Pa., March 29, 2011 /PRNewswire/ — Today MEDRAD,
INC. announced that Jack Darby has joined the company as vice
president of MEDRAD Interventional. In his new role, Darby will act
as general manager of both the diagnostic and therapeutic lines of
the business on a global scale, and will also join MEDRAD’s
executive leadership team.
(Photo: http://photos.prnewswire.com/prnh/20110329/NE73380
)
(Logo:
http://photos.prnewswire.com/prnh/20040309/MEDRADLOGO)
Darby brings almost 20 years of experience in the medical device
industry to the role, with most of those years in the
interventional cardiology space. He comes to MEDRAD from AGA
Medical Corporation, where he most recently served as senior vice
president of Global Marketing and Distributor Sales, gaining deep
experience in the field of the structural heart. Prior to AGA,
Darby spent over 15 years at Cordis, a Johnson & Johnson
company, starting as an angiographic sales representative. His
leadership ability, sales/marketing acumen and international
experience ultimately resulted in his role as vice president of
commercial operations and global stent marketing.
“Jack’s broad base of experience in the interventional space and
combination drug-device products will greatly complement our
patient-focused goals for the interventional business,” says MEDRAD
President and CEO Sam Liang. “With the support of his leadership,
we plan to extend our product innovation and customer satisfaction
footprint within this growing, global market.”
With manufacturing facilities in both Minneapolis, MN and
Pittsburgh, PA, MEDRAD Interventional manufactures and markets
segment-leading medical devices such as AngioJet® Thrombectomy
Systems, MEDRAD Avanta® Fluid Management Injector Systems and
catheters, Mark V ProVis® Angiographic Contrast Injectors,
FETCH® Aspiration Catheters and the GuardD
‘/>”/>
SOURCE
